Literature DB >> 25484508

Posttransplant lymphoproliferative disorder presenting as a small bowel obstruction in a patient with pancreas transplantation alone.

Cleber R Kruel1, Richard M Ruiz1, S Michelle Shiller1, Tiffany L Anthony1, Robert M Goldstein1, Peter T W Kim1, Marlon F Levy1, Gregory J McKenna1, Nicholas Onaca1, Giuliano Testa1, Goran B Klintmalm1.   

Abstract

Posttransplant lymphoproliferative disorder (PTLD) is a well-known complication associated with the transplant recipient. We chronicle a case of PTLD in a failed graft presenting as a small bowel obstruction in a pancreas-only transplant patient. While typical symptoms may be elusive in the complex immunosuppressed patient, graft pain along with persistent graft pancreatitis and a positive Epstein-Barr viremia should raise suspicion for an underlying PTLD.

Entities:  

Year:  2014        PMID: 25484508      PMCID: PMC4255863          DOI: 10.1080/08998280.2014.11929155

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation.

Authors:  Kristine Dyckmans; Evelyne Lerut; Pieter Gillard; Matthias Lannoo; Nadine Ectors; Anne Hoorens; Chantal Mathieu; Willy Coosemans; Yves Vanrenterghem; Dirk Kuypers
Journal:  Nephrol Dial Transplant       Date:  2006-09-05       Impact factor: 5.992

2.  Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis.

Authors:  K Jackson; K Ruppert; R Shapiro
Journal:  Clin Transplant       Date:  2013-10-03       Impact factor: 2.863

3.  Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients.

Authors:  T L Meador; T L Krebs; J J Cheong; B Daly; S Keay; S Bartlett
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

Review 4.  Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?

Authors:  Krzysztof Mucha; Bartosz Foroncewicz; Bogna Ziarkiewicz-Wróblewska; Marek Krawczyk; Jan Lerut; Leszek Paczek
Journal:  Nephrol Dial Transplant       Date:  2010-07       Impact factor: 5.992

5.  Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience.

Authors:  Steven Paraskevas; James E Coad; Angelika Gruessner; Raja Kandaswamy; Abhinav Humar; David E R Sutherland; Rainer W G Gruessner
Journal:  Transplantation       Date:  2005-09-15       Impact factor: 4.939

Review 6.  The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.

Authors:  M A Nalesnik
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

Review 7.  Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines.

Authors:  Anne Parker; Kristin Bowles; J Andrew Bradley; Vincent Emery; Carrie Featherstone; Girish Gupte; Robert Marcus; Jayan Parameshwar; Alan Ramsay; Charles Newstead
Journal:  Br J Haematol       Date:  2010-04-16       Impact factor: 6.998

8.  Epstein-barr virus-associated posttransplant lymphoproliferative disorder of donor origin after simultaneous pancreas-kidney transplantation limited to pancreas allograft: A case report.

Authors:  B Rehbinder; Ch Wullstein; W O Bechstein; M Probst; K Engels; S Kriener; N Döbert; W Schwarz; V Brixner; D Steffan; S Gauer; H Geiger; I A Hauser
Journal:  Am J Transplant       Date:  2006-07-25       Impact factor: 8.086

9.  Posttransplant lymphoproliferative disorder following pancreas transplantation.

Authors:  N Issa; H Amer; P G Dean; W K Kremers; Y C Kudva; N Rostambeigi; F G Cosio; T S Larson; T M Habermann; M D Stegall; M D Griffin
Journal:  Am J Transplant       Date:  2009-06-10       Impact factor: 8.086

10.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.